Technical Analysis for SGMT - Sagimet Biosciences Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| Golden Cross | Bullish | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | -8.69% | |
| Slingshot Bullish | Bullish Swing Setup | -8.69% | |
| Bollinger Band Squeeze | Range Contraction | -8.69% | |
| BB Squeeze + Lower Band Touch | Range Contraction | -8.69% | |
| Lower Bollinger Band Touch | Weakness | -8.69% |
| Alert | Time |
|---|---|
| Down 10% | 1 day ago |
| Down 1 ATR | 1 day ago |
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
| Fell Below Lower Bollinger Band | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases, such as non-alcoholic steatohepatitis, acne, and various cancers. It offers Denifanstat, a fatty acid synthase inhibitor for the treatment of nonalcoholic steatohepatitis. The company also develops TVB-3567, a FASN inhibitor. Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. The company was incorporated in 2006 and is based in San Mateo, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Acne
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Acne
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.71 |
| 52 Week Low | 2.39 |
| Average Volume | 1,811,347 |
| 200-Day Moving Average | 4.52 |
| 50-Day Moving Average | 4.52 |
| 20-Day Moving Average | 5.65 |
| 10-Day Moving Average | 5.71 |
| Average True Range | 0.54 |
| RSI (14) | 41.86 |
| ADX | 34.82 |
| +DI | 23.99 |
| -DI | 25.87 |
| Chandelier Exit (Long, 3 ATRs) | 4.77 |
| Chandelier Exit (Short, 3 ATRs) | 6.21 |
| Upper Bollinger Bands | 6.37 |
| Lower Bollinger Band | 4.93 |
| Percent B (%b) | -0.14 |
| BandWidth | 25.52 |
| MACD Line | 0.24 |
| MACD Signal Line | 0.40 |
| MACD Histogram | -0.1575 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.63 | ||||
| Resistance 3 (R3) | 5.68 | 5.43 | 5.48 | ||
| Resistance 2 (R2) | 5.43 | 5.20 | 5.41 | 5.43 | |
| Resistance 1 (R1) | 5.08 | 5.06 | 4.96 | 5.03 | 5.38 |
| Pivot Point | 4.83 | 4.83 | 4.77 | 4.81 | 4.83 |
| Support 1 (S1) | 4.48 | 4.60 | 4.36 | 4.43 | 4.08 |
| Support 2 (S2) | 4.23 | 4.46 | 4.21 | 4.03 | |
| Support 3 (S3) | 3.88 | 4.23 | 3.98 | ||
| Support 4 (S4) | 3.83 |
